Press & News
We are on a journey to addiction free living and every step counts.
Stay up to date with the latest news and info on our growth.
December 6, 2022
Universal Ibogaine Undertaking Offering Of Convertible Debt Securities And Common Shares
Read More
October 3, 2022
Universal Ibogaine Undertaking Offering Of Convertible Debt Securities And Common Shares
Read More
June 28, 2022
Nick Karos To Present At H.c. Wainwright 1st Annual Mental Health Conference
Read More
June 28, 2022
Universal Ibogaine Advises Departure Of David Danziger From Board Of Directors
Read More
June 28, 2022
Universal Ibogaine Co-founder Dr. Alberto Sola To Present At Research To Reality Conference
Read More
May 12, 2022
Universal Ibogaine Advises Of Departure Of Marilyn Mauritz From Board Of Directors
Read More
March 23, 2022
Universal Ibogaine Expands Research Team With Julie Dumouchel, Director Of Clinical Trials
Read More
February 28, 2022
Universal Ibogaine Announces Approval Of Trading On Otcqb Venture Market
Read More
February 10, 2022
Universal Ibogaine Signs Memorandum Of Understanding With Osoyoos Indian Band
Read More
February 2, 2022
Universal Ibogaine Commences Development Plan At Kelburn In Preparation For Ibogaine Treatments And Provides Update On Drug Supply
Read More
January 14, 2022
Universal Ibogaine Announces World-class Clinical Trial Partners In Advance Of Clinical Trial Application For Ibogaine In Opioid Use Disorder
Read More
December 22, 2021
Universal Ibogaine Announces Expansion Of Executive Team And Grant Of Stock Options
Read More
November 4, 2021
Universal Ibogaine Announces Engagement Of Media And Investor Relations Advisors
Read More
October 5, 2021
Universal Ibogaine Announces Extension Of Convertible Notes Payable And Engagement Of Market Maker Firms
Read More
October 1, 2021
Universal Ibogaine Inc. Announces Tsx-v Final Approval Of Qt, Resumption Of Trading Date And Clarification Of Certain Filing Statement Disclosures
Read More
September 2, 2021
P Squared Renewables Inc. Announces The Completion Of Qualifying Transaction And The Prior Closing Of $6 Million Subscription Receipt Financing
Read More
September 2, 2021
P Squared Renewables Inc. And Universal Ibogaine Inc. Announce Filing Of Filing Statement On Sedar
Read More
July 23, 2021
P Squared Renewables Inc. And Universal Ibogaine Inc. Announce Tsx.v Conditional Approval Of Qualifying Transaction
Read More
July 5, 2021
P Squared Renewables Inc. Provides Update On Con-current Financing And Qt And Announces Changes To Board Of Directors
Read More
June 4, 2021
Psquared Renewables Inc And Universal Ibogaine Inc. Engage Boustead Securities, Llc To Participate In Go-public Financing
Read More
March 30, 2021
P Squared Renewables Inc. Announces Engagement Of Sponsor And Provides Update On Qualifying Transaction With Universal Ibogaine Inc.
Read More
